Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
64.40
+0.20 (0.31%)
May 14, 2025, 2:31 PM CST

Foresee Pharmaceuticals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
977.361,3671,010689.51871.441,145
Upgrade
Short-Term Investments
75-150-100125
Upgrade
Trading Asset Securities
----297.47351.68
Upgrade
Cash & Short-Term Investments
1,0521,3671,160689.511,2691,622
Upgrade
Cash Growth
-3.46%17.90%68.19%-45.66%-21.76%226.86%
Upgrade
Accounts Receivable
59.6732.3365.9116.27--
Upgrade
Other Receivables
12.1526.5522.1810.135.7313.97
Upgrade
Receivables
71.8258.8888.0926.45.7313.97
Upgrade
Inventory
169.95183.87126.8176.4124.8834.11
Upgrade
Prepaid Expenses
86.6132.4823.5622.753.99.71
Upgrade
Other Current Assets
-75192.5--6.62
Upgrade
Total Current Assets
1,3811,8181,591915.061,3031,686
Upgrade
Property, Plant & Equipment
203.04217.62135.01142.3991.19110.8
Upgrade
Other Intangible Assets
116.54117.79126.81140.96155.14209.44
Upgrade
Long-Term Deferred Tax Assets
1.321.311.231.221.11.14
Upgrade
Other Long-Term Assets
4.514.97.76104.3990.5892.06
Upgrade
Total Assets
1,7062,1591,8611,3041,6412,100
Upgrade
Accounts Payable
81.7664.4212.1322.85--
Upgrade
Accrued Expenses
8.9485.57120.7178.4761.6845.8
Upgrade
Short-Term Debt
50150200--30.07
Upgrade
Current Portion of Long-Term Debt
55---20.79
Upgrade
Current Portion of Leases
9.1712.4115.1415.5210.29.38
Upgrade
Current Income Taxes Payable
8.748.8210.424.95--
Upgrade
Current Unearned Revenue
47.9450.03105.481.010.781.52
Upgrade
Other Current Liabilities
0.316.976.966.381.7914.03
Upgrade
Total Current Liabilities
211.84393.21470.83129.1774.45121.59
Upgrade
Long-Term Debt
91.6792.92---63.24
Upgrade
Long-Term Leases
--13.1225.86.456.68
Upgrade
Long-Term Unearned Revenue
72.6272.62131.67237.15239.1777.67
Upgrade
Long-Term Deferred Tax Liabilities
1.421.411.321.321.191.22
Upgrade
Total Liabilities
377.56560.15616.93393.43321.26270.4
Upgrade
Common Stock
1,5481,5481,3581,1821,1791,169
Upgrade
Additional Paid-In Capital
5,9175,9064,6173,4243,3723,319
Upgrade
Retained Earnings
--5,811-4,730-3,693-3,221-2,651
Upgrade
Comprehensive Income & Other
-6,137-44.56-1.49-1.54-10.21-8.06
Upgrade
Shareholders' Equity
1,3291,5991,245910.581,3201,829
Upgrade
Total Liabilities & Equity
1,7062,1591,8611,3041,6412,100
Upgrade
Total Debt
155.84260.33228.2641.3216.65130.15
Upgrade
Net Cash (Debt)
896.521,107931.42648.191,2521,492
Upgrade
Net Cash Growth
3.71%18.85%43.70%-48.24%-16.05%208.45%
Upgrade
Net Cash Per Share
6.328.067.325.4910.6714.71
Upgrade
Filing Date Shares Outstanding
154.26154.79135.82118.17117.94116.94
Upgrade
Total Common Shares Outstanding
154.26154.79135.82118.17117.94116.94
Upgrade
Working Capital
1,1691,4241,120785.891,2291,565
Upgrade
Book Value Per Share
8.6110.339.167.7111.1915.64
Upgrade
Tangible Book Value
1,2121,4811,118769.621,1651,620
Upgrade
Tangible Book Value Per Share
7.869.578.236.519.8813.85
Upgrade
Land
-123.07----
Upgrade
Buildings
-9.96----
Upgrade
Machinery
-226.59209.45171.58136.94144.58
Upgrade
Construction In Progress
--4.920.394.41.31
Upgrade
Leasehold Improvements
-30.4430.447.717.717.71
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.